Home›Articles›What the approval trial and the boxed warning say about TecartusArticleWhat the approval trial and the boxed warning say about TecartusArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnBrexucabtagene autoleucel, Drugs and Medicinal Substances Well-attested SourcesBrexucabtagene autoleucel (Wikipedia)tier 2WikipediaHistoryQuote, HistoryThe complete remission rate after treatment with brexucabtagene autoleucel was 62 percent, with an objective response rate of 87 percent.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.